← Back to headlines
Werewolf Therapeutics Reports Q4 GAAP EPS Beat
Werewolf Therapeutics announced a GAAP EPS of -$0.20, beating analyst estimates by $0.14.
27 Mar, 11:03 — 27 Mar, 11:03
Sources
Showing 1 of 1 sources
Werewolf Therapeutics announced a GAAP EPS of -$0.20, beating analyst estimates by $0.14.
